Abstract
Deafferentation results not only in sensory loss, but also in a variety of alterations in the postsynaptic circuitry. These alterations may have detrimental impact on potential treatment strategies. Progressive loss of photoreceptors in retinal degenerative diseases, such as retinitis pigmentosa and age-related macular degeneration, leads to several changes in the remnant retinal circuitry. Müller glial cells undergo hypertrophy and form a glial seal. The second- and third-order retinal neurons undergo morphological, biochemical and physiological alterations. A result of these alterations is that retinal ganglion cells (RGCs), the output neurons of the retina, become hyperactive and exhibit spontaneous, oscillatory bursts of spikes. This aberrant electrical activity degrades the signal-to-noise ratio in RGC responses, and thus the quality of information they transmit to the brain. These changes in the remnant retina, collectively termed “retinal remodeling”, pose challenges for genetic, cellular and bionic approaches to restore vision. It is therefore crucial to understand the nature of retinal remodeling, how it affects the ability of remnant retina to respond to novel therapeutic strategies, and how to ameliorate its effects. In this article, we discuss these topics, and suggest that the pathological state of the retinal output following photoreceptor loss is reversible, and therefore, amenable to restorative strategies.
Introduction
Loss of photoreceptors, as in retinitis pigmentosa and age-related macular degeneration, leads to extensive, phased, and regressive remodeling in inner retina (Strettoi and Pignatelli, 2000; Marc et al., 2003; Cuenca et al., 2005; Gargini et al., 2007; Barhoum et al., 2008; Nagar et al., 2009). The bipolar cells and horizontal cells show dendritic retraction, axonal sprouting, and ectopic synapse formation (Strettoi et al., 2002, 2003; Nagar et al., 2009). Some of the retinal neurotransmitter receptors, such as type-6 metabotropic glutamate receptors (mGluR6) and GABAC receptors are downregulated, whereas others, such as AMPA, GABAA, and glycine receptors are upregulated following photoreceptor loss (Varela et al., 2003; Marc et al., 2007; Chua et al., 2009; Puthussery et al., 2009; Srivastava et al., 2015). The synaptic proteins in bipolar cells and amacrine cells (ACs) are upregulated, suggesting increased synaptic activity in these cell (Margolis et al., 2008; Borowska et al., 2011; Margolis and Detwiler, 2011; Dagar et al., 2014; Figure 1A). The ACs and retinal ganglion cells (RGCs) retain their gross morphology and receptive field properties, but they show significant molecular and physiological changes. These changes are accompanied by extensive changes in Müller cells (Figure 1B) that lead to formation of a glial seal (Strettoi et al., 2003; Nagar et al., 2009).
Figure 1
A significant outcome of photoreceptor degeneration is that the neuronal networks in inner retina start to oscillate spontaneously, resulting in oscillatory bursts of spikes in RGCs (Pu et al., 2006; Ye and Goo, 2007; Stasheff, 2008; Figure 1C). This degrades the signal-to-noise ratio in RGC responses, and thus the quality of information they transmit (Yee et al., 2012; Toychiev et al., 2013). The oscillatory activity has also been observed in the visual cortex of mice with retinal degeneration and may explain the mechanism underlying photopsia, the perception of spontaneous light flashes in blind patients (Dräger and Hubel, 1978; Heckenlively et al., 1988; Murtha and Stasheff, 2003; Bittner et al., 2009).
It is plausible that retinal remodeling sensitizes the degenerating retina to respond to novel therapeutic strategies, but it may also be a potential hurdle. It is unclear how therapeutic interventions, such as retinal prosthesis, cell/tissue transplantation, and gene therapy, interact with the molecular and circuitry-level changes in inner retina. Further, the glial seal presents a potential physical barrier for prosthetic microelectrodes and transplanted cells. Here, we present an overview of retinal remodeling and some of the emerging therapeutic strategies for retinal degeneration. Since at least some of the early retinal changes following photoreceptor loss are reversible, the future of treatment for retinal degeneration appears promising.
Changes in Retinal Neurons
Loss of photoreceptors triggers a multitude of changes in second-order retinal neurons: bipolar cells and horizontal cells. Bipolar cells retract their dendrites following photoreceptor loss (Strettoi and Pignatelli, 2000; Strettoi et al., 2002; Nagar et al., 2009); however, in models where the photoreceptor loss is incomplete, the bipolar cells tend to form ectopic synapses with the surviving photoreceptors (Peng et al., 2000, 2003; Haverkamp et al., 2006; Marc et al., 2007; Chua et al., 2009; Puthussery et al., 2009). Photoreceptor loss results in reduced mGluR6 expression and reduced ionic currents in ON bipolar cells (Strettoi and Pignatelli, 2000; Varela et al., 2003; Gargini et al., 2007; Puthussery et al., 2009). Further, the ON cone bipolar cells aberrantly express functional ionotropic glutamate receptors (iGluRs; Marc et al., 2007; Chua et al., 2009). However, rod bipolar cells exhibit enhanced sensitivity to GABA (Varela et al., 2003). Horizontal cells decrease in number and show dendritic retraction and axonal growth into the inner nuclear layer (INL) and inner plexiform layer (Strettoi and Pignatelli, 2000; Park et al., 2001; Strettoi et al., 2003; Nagar et al., 2009).
The third-order retinal neurons, ACs and RGCs, have been shown to generally maintain their dendritic geometry, stratification pattern, and intrinsic and receptive field properties (Strettoi and Pignatelli, 2000; Strettoi et al., 2003; Margolis et al., 2008; Mazzoni et al., 2008; Lin and Peng, 2013). However, in late stages, RGCs show altered dendritic branching patterns and even migrate to INL (Marc and Jones, 2003; Jones and Marc, 2005; Jones et al., 2005; O’Brien et al., 2014). In fact, the ACs have been shown to undergo significant biochemical and morphological changes early on. For example, AC-specific synaptic proteins, synapsin-I and syntaxin-I are upregulated (Dagar et al., 2014); calbindin-positve ACs progressively loose functional NMDA receptors (Chua et al., 2009); AII ACs show reduced dab-1 expression and progressively smaller lobular appendages (Barhoum et al., 2008); and putative AII ACs (that express GlyT-1 transporter) extend their processes into and even migrate to the OPL (Park et al., 2004).
Changes in MÜller Glial Cells
Müller glia are involved in several retinal functions, including photoreceptor metabolism, pH maintenance, blood-retina barrier formation, neurotransmitter reuptake, and photopigment recycling (Bunt-Milam and Saari, 1983; Das et al., 1992; Tout et al., 1993; Newman and Reichenbach, 1996). Following photoreceptor degeneration, Müller cells undergo hypertrophy and reactive gliosis, characterized by upregulation of glial fibrillary acidic protein, eventually leading to formation of a glial seal (Strettoi et al., 2002; Nagar et al., 2009; Goel and Dhingra, 2012). The glial seal isolates the remnant neural retina from the retinal pigment epithelium and choroid and could potentially act as a physical barrier for bionic and cell-based strategies aimed at restoring vision (Henriksen et al., 2014). Müller cells have also been shown to dedifferentiate and re-enter cell cycle following photoreceptor loss (see below).
Spontaneous Oscillatory Activity in inner Retina
The retinal remodeling results in dramatic physiological changes in retinal output. Specifically, RGCs start to produce spontaneous oscillatory bursts of spikes and exhibit reduced signal-to-noise ratio in their light responses (Pu et al., 2006; Margolis et al., 2008; Stasheff, 2008; Ryu et al., 2010a,b; Yee et al., 2012; Toychiev et al., 2013).
The oscillatory activity does not originate in RGCs, but is presynaptic (Margolis et al., 2008; Borowska et al., 2011; Menzler and Zeck, 2011). ON-cone bipolar cells, AII ACs, and the gap junctions connecting them may be the source loci (Borowska et al., 2011; Menzler and Zeck, 2011; Trenholm et al., 2012; Choi et al., 2014; Margolis et al., 2014). Both bipolar cells and ACs have been shown to exhibit regenerative activity in in vitro preparations (Solessio et al., 2002; Ma and Pan, 2003; Cembrowski et al., 2012). Interestingly, even remnant cones and horizontal cells exhibit spontaneous oscillatory activity after photoreceptor loss (Haq et al., 2014). The oscillatory activity was recently shown to originate in ON pathway and transfer to OFF pathway via glycinergic, likely the AII ACs (Poria and Dhingra, 2015). As a result, the oscillatory activities in ON and OFF RGCs are 180° out of phase (Margolis et al., 2014). Overall, these observations show that the inner retinal neurons start to oscillate following photoreceptor loss. However, it is not clear how this oscillatory activity would interact with therapeutic interventions, such as retinal prostheses.
Approaches to Treat Retinal Degeneration
Preventive Strategies
Attempts to prevent or slow down the progression of photoreceptor degeneration have shown promise. For example, inhibiting ceramide biosynthesis pathway with myriocin or activating Wnt/β-catenin signaling in the Müller cells slow down the disease progression in rd10 mouse (Strettoi et al., 2010; Patel et al., 2015). Interestingly, raising rd10 mice in enriched environment has also been shown to delay the progression of photoreceptor loss, possibly due to increased expression of CNTF and mTOR (Barone et al., 2012, 2014). Slowing down of photoreceptor degeneration by enriched environment may provide additional benefit if combined with other treatment approaches to restore visual function, not only during development but also in adulthood.
Cell Transplantation
There have been significant attempts to transplant cells of various types in degenerating retina, with varied results. Early studies showed the survival and integration of stem cells, such as embryonic or hematopoietic stem cells in rd mouse retina (Otani et al., 2002, 2004; Meyer et al., 2006). The transplanted photoreceptor precursors have been shown to form rudimentary synapses with rod bipolar cells and partially restore visual function (MacLaren et al., 2006). Recently, Gonzalez-Cordero et al. (2013) transplanted mouse embryonic stem cell-derived photoreceptor precursors in Gnat−/− mouse model, and found that they integrated into the host retina and differentiated to form synapse-like structures. Human embryonic stem cells and induced pluripotent stem cells have also shown promise in restoring vision (Reynolds and Lamba, 2014; Wright et al., 2014).
The glial seal formed by Müller cells is a concern for transplantation strategies, because it can potentially limit the migration of transplanted cells into the retinal layers (Kinouchi et al., 2003). However, pharmacological tools, such as alpha-amino adipic acid or chondroitinase ABC that break the glial seal, could facilitate the migration and integration of the transplanted cells (West et al., 2008; Barber et al., 2013). Alpha-amino adipic acid is a glial toxin that, depending on the dose, can exert a variety of effects on Müller cells, from cell proliferation to cell death and therefore requires careful dose titration to facilitate transplantation (Olney, 1982; Takeda et al., 2008; West et al., 2008). Another concern is related to the ability of the second-order retinal neurons in degenerating retina to receive synaptic inputs from the transplanted cells. Enabling bipolar cells and horizontal cells to extend their dendrites in the absence of photoreceptors would require understanding the signaling pathways that regulate dendritic growth and lamination in these neurons. This is particularly challenging, because such signaling pathways are likely absent or dormant in adult mammalian retina (D’Orazi et al., 2014).
Gene Therapy and Optogenetic Approaches
Gene therapy offers a promising approach to restore vision. Several studies have shown that introducing a missing gene can lead to partial or complete restoration of vision in animal models (Ali et al., 2000; Acland et al., 2001; Alexander et al., 2007; Mancuso et al., 2009; Michalakis et al., 2010; Beltran et al., 2012). The success in animal models has led to human clinical trials to treat Leber’s congenital amaurosis (Bainbridge et al., 2008; Cideciyan et al., 2008; Hauswirth et al., 2008; Maguire et al., 2008). However, although this approach showed improvement in visual function in the short term (~1–3 years), the retina continued to degenerate and visual sensitivity deteriorated over the longer term (~3–6 years; Cideciyan et al., 2013; Bainbridge et al., 2015; Jacobson et al., 2015; Wright, 2015). Designing more efficient vectors for gene delivery and combining gene therapy with measures that slow or arrest retinal degeneration may help prolong the therapeutic efficacy (Cideciyan et al., 2013; Wright, 2015). Another challenge that the gene therapy faces is that inherited retinal degeneration is a heterogeneous disease involving diverse genes, which requires developing mutation-specific therapy for each disease subtype (Hartong et al., 2006; Dalkara et al., 2015).
Alternative approaches that impart light sensitivity by introducing opsins into specific remnant retinal neurons have shown tremendous potential. For example, introducing melanopsin, a native light sensor normally present in a small subset of RGCs, into a wider population of RGCs in mouse resulted in a partial rescue of vision (Lin et al., 2008). However, melanopsin is a high-threshold opsin, which limits its clinical use. Recently, expressing a chimeric protein (opto-mGluR6) that combined mGluR6 and melanopsin in ON bipolar cells produced simple visual behaviors in rd1 mouse (van Wyk et al., 2015). Lagali et al. (2008) expressed channel-rhodopsin-2 (ChR2), a microbial light-gated channel that depolarizes the cell on light exposure, in ON bipolar cells and showed light responses in RGCs; these mice were able to perform optomotor tasks. Similarly, Zhang et al. (2009) expressed the depolarizing ChR2 and hyperpolarizing halorhodopsin in RGCs and showed ON and OFF light responses. In an elegant set of experiments, Busskamp et al. (2010) expressed ChR2 and halorhodopsin in the remnant cone photoreceptors and were able to partially restore vision in blind mice.
Overall, these data demonstrate the tremendous potential of genetic and optogenetics-based approaches in restoring vision. Targeting specific channels in specific cells may be required to achieve more clinically-relevant outcomes. Similarly, a deeper understanding of the changes in gene expression patterns and genetic markers in the remnant retinal neurons would help design specific targeting vectors to successfully treat retinal degeneration.
Photoswitches
Photoswitches are molecules that reversibly change their conformation in response to specific wavelengths of light. Acrylamide-azobenzene-quaternary ammonium (AAQ) and a modified AAQ, DENAQ, act as photoswitches for the K+ channels: their trans form increases neuronal excitability, whereas the cis form decreases neuronal excitability. A single intra-ocular injection of a photoswitch has been shown to confer light sensitivity to RGCs (Polosukhina et al., 2012; Tochitsky et al., 2014). However, these molecules are not cell specific. This could be overcome by engineering a photoswitch that can be targeted to specific cells. A photoswitch expressed with light-gated ionotropic glutamate receptor (LiGluR) specifically in RGCs or ON bipolar cells has been shown to restore vision in mice and canine models of retinal degeneration (Caporale et al., 2011; Gaub et al., 2014).
Retinal Prostheses
Producing artificial vision in blind animals and humans by electrically stimulating the degenerating retina with a prosthetic “chip” is no longer a fantasy. There are two approaches to stimulating the retina: subretinal, where a light-sensitive photodiode array substitutes the missing photoreceptors and stimulates the remnant circuit, and epiretinal, where RGCs are stimulated directly. Devices of both types have been approved for human use and provide measurable visual acuity and rudimentary object localization/recognition (Ahuja et al., 2011; Zrenner et al., 2011; Humayun et al., 2012; da Cruz et al., 2013; Kotecha et al., 2014; Ho et al., 2015; Stingl et al., 2015).
Considering that inner retina responds remarkably to loss of photoreceptors, a biological process, it is unclear how it would respond to an artificial device in the long term. Although the initial success is promising, more work is required to improve specificity, spatial and temporal resolution, contrast sensitivity, and intraocular packaging (Eiber et al., 2013; Zrenner, 2013; Maghami et al., 2014; Weiland and Humayun, 2014). For example, targeting specific ganglion cells could help mimic natural aspects of visual processing (Dorn et al., 2013). Recent work in isolated primate retina showed the potential of improved prosthetic designs in eliciting precisely timed spikes to produce spatiotemporal patterns in RGCs similar to those produced by light stimuli (Jepson et al., 2014a,b). Recent advances in powering a subretinal electrode array wirelessly will resolve the problem of implanting the cumbersome battery packs (Mathieson et al., 2012; Mandel et al., 2013; Lorach et al., 2015a,b). In a different approach, optoelectronic polymer interface have been shown to impart light sensitivity to degenerate retina ex-vivo, both in subretinal and epiretinal configurations (Ghezzi et al., 2013; Gautam et al., 2014). Even with these significant advances, it remains unclear how a subretinal prosthetic device would employ the remodeled remnant retinal circuitry or how an epiretinal device would stimulate specific RGCs through the glial seal to produce meaningful vision for blind patients.
Endogenous Regeneration
Several recent discoveries suggest that the endogenous regenerative capacity of retina can be exploited for repair. Specifically, Müller glia have been shown to exhibit stem cell properties. In response to retinal injury in fish, Müller cells and the ciliary marginal zone cells can regenerate all retinal neurons, resulting in complete functional recovery (Braisted et al., 1994; Fimbel et al., 2007; Thummel et al., 2008). Since Müller glia are among the last retinal cells to develop, it is possible that they do not undergo the irreversible cell fate determination event (Young, 1985; Cepko et al., 1996; Jadhav et al., 2009). They share 43% similarity in the expressed genes with the retinal progenitor cells and retain most of the genes expressed by the late retinal progenitor cells (Blackshaw et al., 2004; Livesey et al., 2004; Roesch et al., 2008; Jadhav et al., 2009). Müller glia have been considered the dormant stem cells of retina (Jadhav et al., 2009).
The mammalian Müller glia, however, have limited regenerative capacity. They have been shown to re-enter cell cycle and express stem-cell and mature-retinal-cell markers, such as PKC-α, NSE, recoverin, rhodopsin, calretinin, NeuN, and prox1 following photoreceptor loss, but they do not generate functional photoreceptors (Ooto et al., 2004; Karl et al., 2008; Wan et al., 2008; Zhao et al., 2010; Goel and Dhingra, 2012; Greferath et al., 2015).
Several approaches to promote neuroprotective and regenerative capacity of Müller glia in mammalian retina seem promising. Müller glia secrete several neuroprotective growth factors, such as bFGF, BDNF, GDNF, NGF, and CNTF (Wen et al., 1995; Chu et al., 1998; Liu et al., 1998; Harada et al., 2000; Peterson et al., 2000; Delyfer et al., 2005; Hauck et al., 2006). Application of FGF and CNTF helps mammalian Müller glia differentiate into retinal neurons in vitro (Lawrence et al., 2007; Giannelli et al., 2011; Jayaram et al., 2014). Müller glia could be used as scaffolds to express neuroprotective molecules, such as GDNF, to slow down the progression of degeneration (Klimczak et al., 2009; Dalkara et al., 2011). Expressing specific genes in Müller glia can lead to their differentiation into specific retinal neurons (Ooto et al., 2004). In addition, transcriptomic analyses of Müller glia from degenerating retinas have revealed changes in glutathione metabolism and peroxide detoxification, which could potentially confer neuroprotection (Roesch et al., 2012).
Conclusions and Future Directions
More than a decade of research has revealed the molecular to circuit-level details of retinal remodeling, but several challenges remain. For example, it is unclear how events, such as dendritic retraction, aberrant neuritogenesis, cell migration, and ectopic synapse formation, are connected temporally. We know how some retinal neurotransmitter receptors or ion channels respond to loss of photoreceptors, but it is unclear how this occurs at the level of specific cell types.
Longitudinal transcriptional profiling of specific cells may help identify potential signaling pathways and molecular targets, as has been done for amyotrophic lateral sclerosis (Saxena et al., 2009). The GENSAT mouse lines expressing GFP in specific retinal cells may also be valuable (Siegert et al., 2009, 2012). Specific cells can be sorted by FACS, and their transcriptome analyzed by RNA sequencing during or following photoreceptor degeneration; this could help identify the signaling molecules and pathways involved in remodeling, and thus potentially help discover novel interventional strategies (Sharma et al., 2015; Yang et al., 2015).
Many of the promising treatment approaches, such as retinal prostheses, gene therapy, optogenetics, photoswitches, and endogenous regeneration will likely benefit from advances in specific cell targeting. One possibility that has not been explored sufficiently is to combine these treatment approaches. A recent study combined optogenetic expression of ChR2 in RGCs with retinal prostheses and showed that driving the stimulator with retina’s neural code elicits RGC firing similar to normal retina (Nirenberg and Pandarinath, 2012). It is plausible that combining prosthetic stimulation or gene therapy with approaches, such as pharmacological agents that slow down the degeneration or promote endogenous regeneration, or those that abolish oscillatory activity in degenerated retina could expedite the progress in restoring vision for blind patients.
Recent work on biochemical mechanisms underlying oscillatory activity in retina may help design newer drug therapies for retinal degeneration. For example, blocking gap junctions with meclofenamic acid has been shown to eliminate oscillatory activity in RGCs (Trenholm et al., 2012; Menzler et al., 2014). Similarly, blocking glycinergic signaling with strychnine removes oscillatory activity in OFF RGCs (Poria and Dhingra, 2015). Although more work is required, a notable outcome is that oscillatory activity in RGCs is acutely reversible, implying that it is not a result of any massive or structural remodeling and that the biochemical and physiological changes in inner retina may be amenable to restoration strategies (Dagar et al., 2014).
Funding
This study was funded by National Brain Research Centre, India.
Statements
Author contributions
All listed authors, have made substantial, direct, and intellectual contribution to the work, and approved it for publication.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AclandG. M.AguirreG. D.RayJ.ZhangQ.AlemanT. S.CideciyanA. V.et al. (2001). Gene therapy restores vision in a canine model of childhood blindness. Nat. Genet.28, 92–95. 10.1038/ng0501-92
2
AhujaA. K.DornJ. D.CaspiA.McmahonM. J.DagnelieG.DacruzL.et al. (2011). Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br. J. Ophthalmol.95, 539–543. 10.1136/bjo.2010.179622
3
AlexanderJ. J.UminoY.EverhartD.ChangB.MinS. H.LiQ.et al. (2007). Restoration of cone vision in a mouse model of achromatopsia. Nat. Med.13, 685–687. 10.1038/nm1596
4
AliR. R.SarraG. M.StephensC.AlwisM. D.BainbridgeJ. W.MunroP. M.et al. (2000). Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat. Genet.25, 306–310. 10.1038/77068
5
BainbridgeJ. W.MehatM. S.SundaramV.RobbieS. J.BarkerS. E.RipamontiC.et al. (2015). Long-term effect of gene therapy on Leber’s congenital amaurosis. N. Engl. J. Med.372, 1887–1897. 10.1056/NEJMoa1414221
6
BainbridgeJ. W.SmithA. J.BarkerS. S.RobbieS.HendersonR.BalagganK.et al. (2008). Effect of gene therapy on visual function in Leber’s congenital amaurosis. N. Engl. J. Med.358, 2231–2239. 10.1056/NEJMoa0802268
7
BarberA. C.HippertC.DuranY.WestE. L.BainbridgeJ. W.Warre-CornishK.et al. (2013). Repair of the degenerate retina by photoreceptor transplantation. Proc. Natl. Acad. Sci. U S A110, 354–359. 10.1073/pnas.1212677110
8
BarhoumR.Martínez-NavarreteG.CorrochanoS.GermainF.Fernandez-SanchezL.de la RosaE. J.et al. (2008). Functional and structural modifications during retinal degeneration in the rd10 mouse. Neuroscience155, 698–713. 10.1016/j.neuroscience.2008.06.042
9
BaroneI.NovelliE.PianoI.GarginiC.StrettoiE. (2012). Environmental enrichment extends photoreceptor survival and visual function in a mouse model of retinitis pigmentosa. PLoS One7:e50726. 10.1371/journal.pone.0050726
10
BaroneI.NovelliE.StrettoiE. (2014). Long-term preservation of cone photoreceptors and visual acuity in rd10 mutant mice exposed to continuous environmental enrichment. Mol. Vis.20, 1545–1556.
11
BeltranW. A.CideciyanA. V.LewinA. S.IwabeS.KhannaH.SumarokaA.et al. (2012). Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa. Proc. Natl. Acad. Sci. U S A109, 2132–2137. 10.1073/pnas.1118847109
12
BittnerA. K.Diener-WestM.DagnelieG. (2009). A survey of photopsias in self-reported retinitis pigmentosa: location of photopsias is related to disease severity. Retina29, 1513–1521. 10.1097/IAE.0b013e3181af0d57
13
BlackshawS.HarpavatS.TrimarchiJ.CaiL.HuangH.KuoW. P.et al. (2004). Genomic analysis of mouse retinal development. PLoS Biol.2:E247. 10.1371/journal.pbio.0020247
14
BorowskaJ.TrenholmS.AwatramaniG. B. (2011). An intrinsic neural oscillator in the degenerating mouse retina. J. Neurosci.31, 5000–5012. 10.1523/JNEUROSCI.5800-10.2011
15
BraistedJ. E.EssmanT. F.RaymondP. A. (1994). Selective regeneration of photoreceptors in goldfish retina. Development120, 2409–2419.
16
Bunt-MilamA. H.SaariJ. C. (1983). Immunocytochemical localization of two retinoid-binding proteins in vertebrate retina. J. Cell Biol.97, 703–712. 10.1083/jcb.97.3.703
17
BusskampV.DuebelJ.BalyaD.FradotM.VineyT. J.SiegertS.et al. (2010). Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science329, 413–417. 10.1126/science.1190897
18
CaporaleN.KolstadK. D.LeeT.TochitskyI.DalkaraD.TraunerD.et al. (2011). LiGluR restores visual responses in rodent models of inherited blindness. Mol. Ther.19, 1212–1219. 10.1038/mt.2011.103
19
CembrowskiM. S.LoganS. M.TianM.JiaL.LiW.KathW. L.et al. (2012). The mechanisms of repetitive spike generation in an axonless retinal interneuron. Cell Rep1, 155–166. 10.1016/j.celrep.2011.12.006
20
CepkoC. L.AustinC. P.YangX.AlexiadesM.EzzeddineD. (1996). Cell fate determination in the vertebrate retina. Proc. Natl. Acad. Sci. U S A93, 589–595. 10.1073/pnas.93.2.589
21
ChoiH.ZhangL.CembrowskiM. S.SabottkeC. F.MarkowitzA. L.ButtsD. A.et al. (2014). Intrinsic bursting of AII amacrine cells underlies oscillations in the rd1 mouse retina. J. Neurophysiol.112, 1491–1504. 10.1152/jn.00437.2014
22
ChuY.HumphreyM. F.AlderV. V.ConstableI. J. (1998). Immunocytochemical localization of basic fibroblast growth factor and glial fibrillary acidic protein after laser photocoagulation in the Royal College of Surgeons rat. Aust. N. Z. J. Ophthalmol.26, 87–96. 10.1111/j.1442-9071.1998.tb01447.x
23
ChuaJ.FletcherE. L.KalloniatisM. (2009). Functional remodeling of glutamate receptors by inner retinal neurons occurs from an early stage of retinal degeneration. J. Comp. Neurol.514, 473–491. 10.1002/cne.22029
24
CideciyanA. V.AlemanT. S.BoyeS. L.SchwartzS. B.KaushalS.RomanA. J.et al. (2008). Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc. Natl. Acad. Sci. U S A105, 15112–15117. 10.1073/pnas.0807027105
25
CideciyanA. V.JacobsonS. G.BeltranW. A.SumarokaA.SwiderM.IwabeS.et al. (2013). Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc. Natl. Acad. Sci. U S A110, E517–E525. 10.1073/pnas.1218933110
26
CuencaN.PinillaI.SauvéY.LundR. (2005). Early changes in synaptic connectivity following progressive photoreceptor degeneration in RCS rats. Eur. J. Neurosci.22, 1057–1072. 10.1111/j.1460-9568.2005.04300.x
27
da CruzL.ColeyB. F.DornJ.MerliniF.FilleyE.ChristopherP.et al. (2013). The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss. Br. J. Ophthalmol.97, 632–636. 10.1136/bjophthalmol-2012-301525
28
DagarS.NagarS.GoelM.CherukuriP.DhingraN. K. (2014). Loss of photoreceptors results in upregulation of synaptic proteins in bipolar cells and amacrine cells. PLoS One9:e90250. 10.1371/journal.pone.0090250
29
DalkaraD.DuebelJ.SahelJ. A. (2015). Gene therapy for the eye focus on mutation-independent approaches. Curr. Opin. Neurol.28, 51–60. 10.1097/WCO.0000000000000168
30
DalkaraD.KolstadK. D.GuerinK. I.HoffmannN. V.ViselM.KlimczakR. R.et al. (2011). AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa. Mol. Ther.19, 1602–1608. 10.1038/mt.2011.62
31
DasS. R.BhardwajN.KjeldbyeH.GourasP. (1992). Müller cells of chicken retina synthesize 11-cis-retinol. Biochem J.285, 907–913. 10.1042/bj2850907
32
DelyferM. N.SimonuttiM.NeveuxN.LéveillardT.SahelJ. A. (2005). Does GDNF exert its neuroprotective effects on photoreceptors in the rd1 retina through the glial glutamate transporter GLAST?Mol. Vis.11, 677–687.
33
D’OraziF. D.SuzukiS. C.WongR. O. (2014). Neuronal remodeling in retinal circuit assembly, disassembly and reassembly. Trends Neurosci.37, 594–603. 10.1016/j.tins.2014.07.009
34
DornJ. D.AhujaA. K.CaspiA.da CruzL.DagnelieG.SahelJ. A.et al. (2013). The detection of motion by blind subjects with the epiretinal 60-electrode (Argus II) retinal prosthesis. JAMA Ophthalmol.131, 183–189. 10.1001/2013.jamaophthalmol.221
35
DrägerU. C.HubelD. H. (1978). Studies of visual function and its decay in mice with hereditary retinal degeneration. J. Comp. Neurol.180, 85–114. 10.1002/cne.901800107
36
EiberC. D.LovellN. H.SuaningG. J. (2013). Attaining higher resolution visual prosthetics: a review of the factors and limitations. J. Neural Eng.10:011002. 10.1088/1741-2560/10/1/011002
37
FimbelS. M.MontgomeryJ. E.BurketC. T.HydeD. R. (2007). Regeneration of inner retinal neurons after intravitreal injection of ouabain in zebrafish. J. Neurosci.27, 1712–1724. 10.1523/jneurosci.5317-06.2007
38
GarginiC.TerzibasiE.MazzoniF.StrettoiE. (2007). Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: a morphological and ERG study. J. Comp. Neurol.500, 222–238. 10.1002/cne.21144
39
GaubB. M.BerryM. H.HoltA. E.ReinerA.KienzlerM. A.DolgovaN.et al. (2014). Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells. Proc. Natl. Acad. Sci. U S A111, E5574–E5583. 10.1073/pnas.1414162111
40
GautamV.RandD.HaneinY.NarayanK. S. (2014). A polymer optoelectronic interface provides visual cues to a blind retina. Adv. Mater.26, 1751–1756. 10.1002/adma.201304368
41
GhezziD.AntognazzaM. R.MaccaroneR.BellaniS.LanzariniE.MartinoN.et al. (2013). A polymer optoelectronic interface restores light sensitivity in blind rat retinas. Nat. Photonics7, 400–406. 10.1038/nphoton.2013.34
42
GiannelliS. G.DemontisG. C.PertileG.RamaP.BroccoliV. (2011). Adult human Müller glia cells are a highly efficient source of rod photoreceptors. Stem Cells29, 344–356. 10.1002/stem.579
43
GoelM.DhingraN. K. (2012). Müller glia express rhodopsin in a mouse model of inherited retinal degeneration. Neuroscience225, 152–161. 10.1016/j.neuroscience.2012.08.066
44
Gonzalez-CorderoA.WestE. L.PearsonR. A.DuranY.CarvalhoL. S.ChuC. J.et al. (2013). Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina. Nat. Biotechnol.31, 741–747. 10.1038/nbt.2643
45
GreferathU.AndersonE. E.JoblingA. I.VesseyK. A.MartinezG.de IonghR. U.et al. (2015). Inner retinal change in a novel rd1-FTL mouse model of retinal degeneration. Front. Cell. Neurosci.9:293. 10.3389/fncel.2015.00293
46
HaqW.Arango-GonzalezB.ZrennerE.EulerT.SchubertT. (2014). Synaptic remodeling generates synchronous oscillations in the degenerated outer mouse retina. Front. Neural Circuits8:108. 10.3389/fncir.2014.00108
47
HaradaT.HaradaC.NakayamaN.OkuyamaS.YoshidaK.KohsakaS.et al. (2000). Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron26, 533–541. 10.1016/s0896-6273(00)81185-x
48
HartongD. T.BersonE. L.DryjaT. P. (2006). Retinitis pigmentosa. Lancet368, 1795–1809. 10.1016/S0140-6736(06)69740-7
49
HauckS. M.KinklN.DeegC. A.Swiatek-De LangeM.SchöffmannS.UeffingM. (2006). GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells. Mol. Cell. Biol.26, 2746–2757. 10.1128/mcb.26.7.2746-2757.2006
50
HauswirthW. W.AlemanT. S.KaushalS.CideciyanA. V.SchwartzS. B.WangL.et al. (2008). Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum. Gene Ther.19, 979–990. 10.1089/hum.2008.107
51
HaverkampS.MichalakisS.ClaesE.SeeligerM. W.HumphriesP.BielM.et al. (2006). Synaptic plasticity in CNGA3(−/–) mice: cone bipolar cells react on the missing cone input and form ectopic synapses with rods. J. Neurosci.26, 5248–5255. 10.1523/jneurosci.4483-05.2006
52
HeckenlivelyJ. R.YoserS. L.FriedmanL. H.OversierJ. J. (1988). Clinical findings and common symptoms in retinitis pigmentosa. Am. J. Ophthalmol.105, 504–511. 10.1016/0002-9394(88)90242-5
53
HenriksenB. S.MarcR. E.BernsteinP. S. (2014). Optogenetics for retinal disorders. J. Ophthalmic. Vis. Res.9, 374–382. 10.4103/2008-322X.143379
54
HoA. C.HumayunM. S.DornJ. D.Da CruzL.DagnelieG.HandaJ.et al. (2015). Long-term results from an epiretinal prosthesis to restore sight to the blind. Ophthalmology122, 1547–1554. 10.1016/j.ophtha.2015.04.032
55
HumayunM. S.DornJ. D.da CruzL.DagnelieG.SahelJ. A.StangaP. E.et al. (2012). Interim results from the international trial of Second Sight’s visual prosthesis. Ophthalmology119, 779–788. 10.1016/j.ophtha.2011.09.028
56
JacobsonS. G.CideciyanA. V.RomanA. J.SumarokaA.SchwartzS. B.HeonE.et al. (2015). Improvement and decline in vision with gene therapy in childhood blindness. N. Engl. J. Med.372, 1920–1926. 10.1056/nejmoa1412965
57
JadhavA. P.RoeschK.CepkoC. L. (2009). Development and neurogenic potential of Müller glial cells in the vertebrate retina. Prog. Retin. Eye Res.28, 249–262. 10.1016/j.preteyeres.2009.05.002
58
JayaramH.JonesM. F.EastlakeK.CottrillP. B.BeckerS.WisemanJ.et al. (2014). Transplantation of photoreceptors derived from human Müller glia restore rod function in the P23H rat. Stem Cells Transl. Med.3, 323–333. 10.5966/sctm.2013-0112
59
JepsonL. H.HottowyP.MathiesonK.GunningD. E.DabrowskiW.LitkeA. M.et al. (2014a). Spatially patterned electrical stimulation to enhance resolution of retinal prostheses. J. Neurosci.34, 4871–4881. 10.1523/JNEUROSCI.2882-13.2014
60
JepsonL. H.HottowyP.WeinerG. A.DabrowskiW.LitkeA. M.ChichilniskyE. J. (2014b). High-fidelity reproduction of spatiotemporal visual signals for retinal prosthesis. Neuron83, 87–92. 10.1016/j.neuron.2014.04.044
61
JonesB. W.MarcR. E. (2005). Retinal remodeling during retinal degeneration. Exp. Eye Res.81, 123–137. 10.1016/j.exer.2005.03.006
62
JonesB. W.WattC. B.MarcR. E. (2005). Retinal remodelling. Clin. Exp. Optom.88, 282–291. 10.1111/j.1444-0938.2005.tb06712.x
63
KarlM. O.HayesS.NelsonB. R.TanK.BuckinghamB.RehT. A. (2008). Stimulation of neural regeneration in the mouse retina. Proc. Natl. Acad. Sci. U S A105, 19508–19513. 10.1073/pnas.0807453105
64
KinouchiR.TakedaM.YangL.WilhelmssonU.LundkvistA.PeknyM.et al. (2003). Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat. Neurosci.6, 863–868. 10.1038/nn1088
65
KlimczakR. R.KoerberJ. T.DalkaraD.FlanneryJ. G.SchafferD. V. (2009). A novel adeno-associated viral variant for efficient and selective intravitreal transduction of rat Müller cells. PLoS One4:e7467. 10.1371/journal.pone.0007467
66
KotechaA.ZhongJ.StewartD.da CruzL. (2014). The Argus II prosthesis facilitates reaching and grasping tasks: a case series. BMC Ophthalmol.14:71. 10.1186/1471-2415-14-71
67
LagaliP. S.BalyaD.AwatramaniG. B.MünchT. A.KimD. S.BusskampV.et al. (2008). Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nat. Neurosci.11, 667–675. 10.1038/nn.2117
68
LawrenceJ. M.SinghalS.BhatiaB.KeeganD. J.RehT. A.LuthertP. J.et al. (2007). MIO-M1 cells and similar Müller glial cell lines derived from adult human retina exhibit neural stem cell characteristics. Stem Cells25, 2033–2043. 10.1634/stemcells.2006-0724
69
LinB.KoizumiA.TanakaN.PandaS.MaslandR. H. (2008). Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin. Proc. Natl. Acad. Sci. U S A105, 16009–16014. 10.1073/pnas.0806114105
70
LinB.PengE. B. (2013). Retinal ganglion cells are resistant to photoreceptor loss in retinal degeneration. PLoS One8:e68084. 10.1371/journal.pone.0068084
71
LiuC.PengM.LatiesA. M.WenR. (1998). Preconditioning with bright light evokes a protective response against light damage in the rat retina. J. Neurosci.18, 1337–1344.
72
LiveseyF. J.YoungT. L.CepkoC. L. (2004). An analysis of the gene expression program of mammalian neural progenitor cells. Proc. Natl. Acad. Sci. U S A101, 1374–1379. 10.1073/pnas.0307014101
73
LorachH.GoetzG.MandelY.LeiX.KaminsT. I.MathiesonK.et al. (2015a). Performance of photovoltaic arrays in-vivo and characteristics of prosthetic vision in animals with retinal degeneration. Vision Res.111, 142–148. 10.1016/j.visres.2014.09.007
74
LorachH.GoetzG.SmithR.LeiX.MandelY.KaminsT.et al. (2015b). Photovoltaic restoration of sight with high visual acuity. Nat. Med.21, 476–482. 10.1038/nm.3851
75
MaY. P.PanZ. H. (2003). Spontaneous regenerative activity in mammalian retinal bipolar cells: roles of multiple subtypes of voltage-dependent Ca2+ channels. Vis. Neurosci.20, 131–139. 10.1017/s0952523803202042
76
MacLarenR. E.PearsonR. A.MacNeilA.DouglasR. H.SaltT. E.AkimotoM.et al. (2006). Retinal repair by transplantation of photoreceptor precursors. Nature444, 203–207. 10.1038/nature05161
77
MaghamiM. H.SodagarA. M.LashayA.Riazi-EsfahaniH.Riazi-EsfahaniM. (2014). Visual prostheses: the enabling technology to give sight to the blind. J. Ophthalmic. Vis. Res.9, 494–505. 10.4103/2008-322x.150830
78
MaguireA. M.SimonelliF.PierceE. A.PughE. N.Jr.MingozziF.BennicelliJ.et al. (2008). Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl. J. Med.358, 2240–2248. 10.1056/NEJMoa0802315
79
MancusoK.HauswirthW. W.LiQ.ConnorT. B.KuchenbeckerJ. A.MauckM. C.et al. (2009). Gene therapy for red-green colour blindness in adult primates. Nature461, 784–787. 10.1038/nature08401
80
MandelY.GoetzG.LavinskyD.HuieP.MathiesonK.WangL.et al. (2013). Cortical responses elicited by photovoltaic subretinal prostheses exhibit similarities to visually evoked potentials. Nat. Commun.4:1980. 10.1038/ncomms2980
81
MarcR. E.JonesB. W. (2003). Retinal remodeling in inherited photoreceptor degenerations. Mol. Neurobiol.28, 139–147. 10.1385/mn:28:2:139
82
MarcR. E.JonesB. W.AndersonJ. R.KinardK.MarshakD. W.WilsonJ. H.et al. (2007). Neural reprogramming in retinal degeneration. Invest. Ophthalmol. Vis. Sci.48, 3364–3371. 10.1167/iovs.07-0032
83
MarcR. E.JonesB. W.WattC. B.StrettoiE. (2003). Neural remodeling in retinal degeneration. Prog. Retin. Eye Res.22, 607–655. 10.1016/s1350-9462(03)00039-9
84
MargolisD. J.DetwilerP. B. (2011). Cellular origin of spontaneous ganglion cell spike activity in animal models of retinitis pigmentosa. J. Ophthalmol.2011:6. 10.1155/2011/507037
85
MargolisD. J.GartlandA. J.SingerJ. H.DetwilerP. B. (2014). Network oscillations drive correlated spiking of ON and OFF ganglion cells in the rd1 mouse model of retinal degeneration. PLoS One9:e86253. 10.1371/journal.pone.0086253
86
MargolisD. J.NewkirkG.EulerT.DetwilerP. B. (2008). Functional stability of retinal ganglion cells after degeneration-induced changes in synaptic input. J. Neurosci.28, 6526–6536. 10.1523/JNEUROSCI.1533-08.2008
87
MathiesonK.LoudinJ.GoetzG.HuieP.WangL.KaminsT. I.et al. (2012). Photovoltaic retinal prosthesis with high pixel density. Nat. Photonics6, 391–397. 10.1038/nphoton.2012.104
88
MazzoniF.NovelliE.StrettoiE. (2008). Retinal ganglion cells survive and maintain normal dendritic morphology in a mouse model of inherited photoreceptor degeneration. J. Neurosci.28, 14282–14292. 10.1523/JNEUROSCI.4968-08.2008
89
MenzlerJ.ChannappaL.ZeckG. (2014). Rhythmic ganglion cell activity in bleached and blind adult mouse retinas. PLoS One9:e106047. 10.1371/journal.pone.0106047
90
MenzlerJ.ZeckG. (2011). Network oscillations in rod-degenerated mouse retinas. J. Neurosci.31, 2280–2291. 10.1523/JNEUROSCI.4238-10.2011
91
MeyerJ. S.KatzM. L.MaruniakJ. A.KirkM. D. (2006). Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors. Stem Cells24, 274–283. 10.1634/stemcells.2005-0059
92
MichalakisS.MühlfriedelR.TanimotoN.KrishnamoorthyV.KochS.FischerM. D.et al. (2010). Restoration of cone vision in the CNGA3−/− mouse model of congenital complete lack of cone photoreceptor function. Mol. Ther.18, 2057–2063. 10.1038/mt.2010.149
93
MurthaT.StasheffS. F. (2003). Visual dysfunction in retinal and optic nerve disease. Neurol. Clin.21, 445–481. 10.1016/s0733-8619(02)00108-1
94
NagarS.KrishnamoorthyV.CherukuriP.JainV.DhingraN. K. (2009). Early remodeling in an inducible animal model of retinal degeneration. Neuroscience160, 517–529. 10.1016/j.neuroscience.2009.02.056
95
NewmanE.ReichenbachA. (1996). The Müller cell: a functional element of the retina. Trends Neurosci.19, 307–312. 10.1016/0166-2236(96)10040-0
96
NirenbergS.PandarinathC. (2012). Retinal prosthetic strategy with the capacity to restore normal vision. Proc. Natl. Acad. Sci. U S A109, 15012–15017. 10.1073/pnas.1207035109
97
O’BrienE. E.GreferathU.FletcherE. L. (2014). The effect of photoreceptor degeneration on ganglion cell morphology. J. Comp. Neurol.522, 1155–1170. 10.1002/cne.23487
98
OlneyJ. W. (1982). The toxic effects of glutamate and related compounds in the retina and the brain. Retina2, 341–359. 10.1097/00006982-198200000-00020
99
OotoS.AkagiT.KageyamaR.AkitaJ.MandaiM.HondaY.et al. (2004). Potential for neural regeneration after neurotoxic injury in the adult mammalian retina. Proc. Natl. Acad. Sci. U S A101, 13654–13659. 10.1073/pnas.0402129101
100
OtaniA.DorrellM. I.KinderK.MorenoS. K.NusinowitzS.BaninE.et al. (2004). Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J. Clin. Invest.114, 765–774. 10.1172/jci200421686
101
OtaniA.KinderK.EwaltK.OteroF. J.SchimmelP.FriedlanderM. (2002). Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med.8, 1004–1010. 10.1038/nm744
102
ParkS. J.KimI. B.ChoiK. R.MoonJ. I.OhS. J.ChungJ. W.et al. (2001). Reorganization of horizontal cell processes in the developing FVB/N mouse retina. Cell Tissue Res.306, 341–346. 10.1007/s004410100453
103
ParkS. J.LimE. J.OhS. J.ChungJ. W.RickmanD. W.MoonJ. I.et al. (2004). Ectopic localization of putative AII amacrine cells in the outer plexiform layer of the developing FVB/N mouse retina. Cell Tissue Res.315, 407–412. 10.1007/s00441-003-0844-8
104
PatelA. K.SurapaneniK.YiH.NakamuraR. E.KarliS. Z.SyedaS.et al. (2015). Activation of Wnt/beta-catenin signaling in Müller glia protects photoreceptors in a mouse model of inherited retinal degeneration. Neuropharmacology91, 1–12. 10.1016/j.neuropharm.2014.11.015
105
PengY. W.HaoY.PettersR. M.WongF. (2000). Ectopic synaptogenesis in the mammalian retina caused by rod photoreceptor-specific mutations. Nat. Neurosci.3, 1121–1127. 10.1038/80639
106
PengY. W.SendaT.HaoY.MatsunoK.WongF. (2003). Ectopic synaptogenesis during retinal degeneration in the royal college of surgeons rat. Neuroscience119, 813–820. 10.1016/s0306-4522(03)00153-2
107
PetersonW. M.WangQ.TzekovaR.WiegandS. J. (2000). Ciliary neurotrophic factor and stress stimuli activate the Jak-STAT pathway in retinal neurons and glia. J. Neurosci.20, 4081–4090.
108
PolosukhinaA.LittJ.TochitskyI.NemargutJ.SychevY.De KouchkovskyI.et al. (2012). Photochemical restoration of visual responses in blind mice. Neuron75, 271–282. 10.1016/j.neuron.2012.05.022
109
PoriaD.DhingraN. K. (2015). Spontaneous oscillatory activity in rd1 mouse retina is transferred from ON pathway to OFF pathway via glycinergic synapse. J. Neurophysiol.113, 420–425. 10.1152/jn.00702.2014
110
PuM.XuL.ZhangH. (2006). Visual response properties of retinal ganglion cells in the royal college of surgeons dystrophic rat. Invest. Ophthalmol. Vis. Sci.47, 3579–3585. 10.1167/iovs.05-1450
111
PuthusseryT.Gayet-PrimoJ.PandeyS.DuvoisinR. M.TaylorW. R. (2009). Differential loss and preservation of glutamate receptor function in bipolar cells in the rd10 mouse model of retinitis pigmentosa. Eur. J. Neurosci.29, 1533–1542. 10.1111/j.1460-9568.2009.06728.x
112
ReynoldsJ.LambaD. A. (2014). Human embryonic stem cell applications for retinal degenerations. Exp. Eye Res.123, 151–160. 10.1016/j.exer.2013.07.010
113
RoeschK.JadhavA. P.TrimarchiJ. M.StadlerM. B.RoskaB.SunB. B.et al. (2008). The transcriptome of retinal Müller glial cells. J. Comp. Neurol.509, 225–238. 10.1002/cne.21730
114
RoeschK.StadlerM. B.CepkoC. L. (2012). Gene expression changes within Müller glial cells in retinitis pigmentosa. Mol. Vis.18, 1197–1214.
115
RyuS. B.YeJ. H.GooY. S.KimC. H.KimK. H. (2010a). Decoding of retinal ganglion cell spike trains evoked by temporally patterned electrical stimulation. Brain Res.1348, 71–83. 10.1016/j.brainres.2010.06.044
116
RyuS. B.YeJ. H.GooY. S.KimC. H.KimK. H. (2010b). Temporal response properties of retinal ganglion cells in rd1 mice evoked by amplitude-modulated electrical pulse trains. Invest. Ophthalmol. Vis. Sci.51, 6762–6769. 10.1167/iovs.10-5577
117
SaxenaS.CabuyE.CaroniP. (2009). A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci.12, 627–636. 10.1038/nn.2297
118
SharmaD.KimM. S.D’MelloS. R. (2015). Transcriptome profiling of expression changes during neuronal death by RNA-Seq. Exp. Biol. Med. (Maywood)240, 242–251. 10.1177/1535370214551688
119
SiegertS.CabuyE.ScherfB. G.KohlerH.PandaS.LeY. Z.et al. (2012). Transcriptional code and disease map for adult retinal cell types. Nat. Neurosci.15, 487–495, S481–482. 10.1038/nn.3032
120
SiegertS.ScherfB. G.Del PuntaK.DidkovskyN.HeintzN.RoskaB. (2009). Genetic address book for retinal cell types. Nat. Neurosci.12, 1197–1204. 10.1038/nn.2370
121
SolessioE.VighJ.CuencaN.RappK.LasaterE. M. (2002). Membrane properties of an unusual intrinsically oscillating, wide-field teleost retinal amacrine cell. J. Physiol.544, 831–847. 10.1113/jphysiol.2002.021899
122
SrivastavaP.Sinha-MahapatraS. K.GhoshA.SrivastavaI.DhingraN. K. (2015). Differential alterations in the expression of neurotransmitter receptors in inner retina following loss of photoreceptors in rd1 mouse. PLoS One10:e0123896. 10.1371/journal.pone.0123896
123
StasheffS. F. (2008). Emergence of sustained spontaneous hyperactivity and temporary preservation of OFF responses in ganglion cells of the retinal degeneration (rd1) mouse. J. Neurophysiol.99, 1408–1421. 10.1152/jn.00144.2007
124
StinglK.Bartz-SchmidtK. U.BeschD.CheeC. K.CottriallC. L.GekelerF.et al. (2015). Subretinal visual implant alpha IMS–clinical trial interim report. Vision Res.111, 149–160. 10.1016/j.visres.2015.03.001
125
StrettoiE.GarginiC.NovelliE.SalaG.PianoI.GascoP.et al. (2010). Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa. Proc. Natl. Acad. Sci. U S A107, 18706–18711. 10.1073/pnas.1007644107
126
StrettoiE.PignatelliV. (2000). Modifications of retinal neurons in a mouse model of retinitis pigmentosa. Proc. Natl. Acad. Sci. U S A97, 11020–11025. 10.1073/pnas.190291097
127
StrettoiE.PignatelliV.RossiC.PorciattiV.FalsiniB. (2003). Remodeling of second-order neurons in the retina of rd/rd mutant mice. Vision Res.43, 867–877. 10.1016/s0042-6989(02)00594-1
128
StrettoiE.PorciattiV.FalsiniB.PignatelliV.RossiC. (2002). Morphological and functional abnormalities in the inner retina of the rd/rd mouse. J. Neurosci.22, 5492–5504.
129
TakedaM.TakamiyaA.JiaoJ. W.ChoK. S.TrevinoS. G.MatsudaT.et al. (2008). α-Aminoadipate induces progenitor cell properties of Müller glia in adult mice. Invest. Ophthalmol. Vis. Sci.49, 1142–1150. 10.1167/iovs.07-0434
130
ThummelR.KassenS. C.EnrightJ. M.NelsonC. M.MontgomeryJ. E.HydeD. R. (2008). Characterization of Müller glia and neuronal progenitors during adult zebrafish retinal regeneration. Exp. Eye Res.87, 433–444. 10.1016/j.exer.2008.07.009
131
TochitskyI.PolosukhinaA.DegtyarV. E.GalleraniN.SmithC. M.FriedmanA.et al. (2014). Restoring visual function to blind mice with a photoswitch that exploits electrophysiological remodeling of retinal ganglion cells. Neuron81, 800–813. 10.1016/j.neuron.2014.01.003
132
ToutS.Chan-LingT.HollanderH.StoneJ. (1993). The role of Müller cells in the formation of the blood-retinal barrier. Neuroscience55, 291–301. 10.1016/0306-4522(93)90473-s
133
ToychievA. H.IvanovaE.YeeC. W.SagdullaevB. T. (2013). Block of gap junctions eliminates aberrant activity and restores light responses during retinal degeneration. J. Neurosci.33, 13972–13977. 10.1523/JNEUROSCI.2399-13.2013
134
TrenholmS.BorowskaJ.ZhangJ.HoggarthA.JohnsonK.BarnesS.et al. (2012). Intrinsic oscillatory activity arising within the electrically coupled AII amacrine-ON cone bipolar cell network is driven by voltage-gated Na+ channels. J. Physiol.590, 2501–2517. 10.1113/jphysiol.2011.225060
135
van WykM.Pielecka-FortunaJ.LowelS.KleinlogelS. (2015). Restoring the ON switch in blind retinas: opto-mGluR6, a next-generation, cell-tailored optogenetic tool. PLoS Biol.13:e1002143. 10.1371/journal.pbio.1002143
136
VarelaC.IgartuaI.De la RosaE. J.De la VillaP. (2003). Functional modifications in rod bipolar cells in a mouse model of retinitis pigmentosa. Vision Res.43, 879–885. 10.1016/s0042-6989(02)00493-5
137
WanJ.ZhengH.ChenZ. L.XiaoH. L.ShenZ. J.ZhouG. M. (2008). Preferential regeneration of photoreceptor from Müller glia after retinal degeneration in adult rat. Vision Res.48, 223–234. 10.1016/j.visres.2007.11.002
138
WeilandJ. D.HumayunM. S. (2014). Retinal prosthesis. IEEE Trans. Biomed. Eng.61, 1412–1424. 10.1109/TBME.2014.2314733
139
WenR.SongY.ChengT.MatthesM. T.YasumuraD.LaVailM. M.et al. (1995). Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina. J. Neurosci.15, 7377–7385.
140
WestE. L.PearsonR. A.TschernutterM.SowdenJ. C.MacLarenR. E.AliR. R. (2008). Pharmacological disruption of the outer limiting membrane leads to increased retinal integration of transplanted photoreceptor precursors. Exp. Eye Res.86, 601–611. 10.1016/j.exer.2008.01.004
141
WrightA. F. (2015). Long-term effects of retinal gene therapy in childhood blindness. N Engl. J. Med.372, 1954–1955. 10.1056/NEJMe1503419
142
WrightL. S.PhillipsM. J.PinillaI.HeiD.GammD. M. (2014). Induced pluripotent stem cells as custom therapeutics for retinal repair: progress and rationale. Exp. Eye Res.123, 161–172. 10.1016/j.exer.2013.12.001
143
YangH. J.RatnapriyaR.CogliatiT.KimJ. W.SwaroopA. (2015). Vision from next generation sequencing: multi-dimensional genome-wide analysis for producing gene regulatory networks underlying retinal development, aging and disease. Prog. Retin. Eye Res.46, 1–30. 10.1016/j.preteyeres.2015.01.005
144
YeJ. H.GooY. S. (2007). The slow wave component of retinal activity in rd/rd mice recorded with a multi-electrode array. Physiol. Meas.28, 1079–1088. 10.1088/0967-3334/28/9/009
145
YeeC. W.ToychievA. H.SagdullaevB. T. (2012). Network deficiency exacerbates impairment in a mouse model of retinal degeneration. Front. Syst. Neurosci.6:8. 10.3389/fnsys.2012.00008
146
YoungR. W. (1985). Cell differentiation in the retina of the mouse. Anat. Rec.212, 199–205. 10.1002/ar.1092120215
147
ZhangY.IvanovaE.BiA.PanZ. H. (2009). Ectopic expression of multiple microbial rhodopsins restores ON and OFF light responses in retinas with photoreceptor degeneration. J. Neurosci.29, 9186–9196. 10.1523/JNEUROSCI.0184-09.2009
148
ZhaoT. T.TianC. Y.YinZ. Q. (2010). Activation of Müller cells occurs during retinal degeneration in RCS rats. Adv. Exp. Med. Biol.664, 575–583. 10.1007/978-1-4419-1399-9_66
149
ZrennerE. (2013). Fighting blindness with microelectronics. Sci. Transl. Med.5:210ps216. 10.1126/scitranslmed.3007399
150
ZrennerE.Bartz-SchmidtK. U.BenavH.BeschD.BruckmannA.GabelV. P.et al. (2011). Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc. Biol. Sci.278, 1489–1497. 10.1098/rspb.2010.1747
Summary
Keywords
retinal degeneration, oscillatory activity, retinal prostheses, stem cells, optogenetics
Citation
Krishnamoorthy V, Cherukuri P, Poria D, Goel M, Dagar S and Dhingra NK (2016) Retinal Remodeling: Concerns, Emerging Remedies and Future Prospects. Front. Cell. Neurosci. 10:38. doi: 10.3389/fncel.2016.00038
Received
31 August 2015
Accepted
01 February 2016
Published
17 February 2016
Volume
10 - 2016
Edited by
Steven F. Stasheff, University of Iowa, USA
Reviewed by
Jose F. Maya-Vetencourt, Italian Institute of Technology, Italy; Michael Kalloniatis, University of New South Wales, Australia
Updates
Copyright
© 2016 Krishnamoorthy, Cherukuri, Poria, Goel, Dagar and Dhingra.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Narender K. Dhingra narender.dhingra@gmail.com
†These authors have contributed equally to this work.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.